EP4232149A4 - Composés et procédés pour le traitement de troubles oculaires - Google Patents
Composés et procédés pour le traitement de troubles oculaires Download PDFInfo
- Publication number
- EP4232149A4 EP4232149A4 EP21882226.0A EP21882226A EP4232149A4 EP 4232149 A4 EP4232149 A4 EP 4232149A4 EP 21882226 A EP21882226 A EP 21882226A EP 4232149 A4 EP4232149 A4 EP 4232149A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compounds
- treatment
- methods
- ocular diseases
- ocular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063094793P | 2020-10-21 | 2020-10-21 | |
| US202163170988P | 2021-04-05 | 2021-04-05 | |
| PCT/IB2021/000707 WO2022084738A2 (fr) | 2020-10-21 | 2021-10-20 | Composés et procédés pour le traitement de troubles oculaires |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4232149A2 EP4232149A2 (fr) | 2023-08-30 |
| EP4232149A4 true EP4232149A4 (fr) | 2024-12-11 |
Family
ID=81291739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP21882226.0A Pending EP4232149A4 (fr) | 2020-10-21 | 2021-10-20 | Composés et procédés pour le traitement de troubles oculaires |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4232149A4 (fr) |
| JP (1) | JP2023546453A (fr) |
| KR (1) | KR20230110515A (fr) |
| AU (1) | AU2021363702A1 (fr) |
| CA (1) | CA3196145A1 (fr) |
| IL (1) | IL302173A (fr) |
| MX (1) | MX2023004537A (fr) |
| WO (1) | WO2022084738A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7700045B2 (ja) | 2019-04-18 | 2025-06-30 | アズーラ オフサルミックス エルティーディー． | 眼障害を処置するための化合物および方法 |
| US11459351B1 (en) | 2021-04-05 | 2022-10-04 | Azura Ophthalmics Ltd. | Compounds and methods for the treatment of ocular disorders |
| WO2024100454A2 (fr) * | 2022-11-11 | 2024-05-16 | Azura Ophthalmics Ltd. | Composition et procédés pour améliorer les signes et les symptômes de troubles oculaires |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013003731A2 (fr) * | 2011-06-29 | 2013-01-03 | Insite Vision Incorporated | Méthodes permettant de traiter un dysfonctionnement récurrent des glandes de meibomius et de réduire la fréquence de récurrence |
| WO2018215638A1 (fr) * | 2017-05-26 | 2018-11-29 | Novaliq Gmbh | Compositions pharmaceutiques contenant de l'azithromycine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20040849A2 (en) * | 2002-02-15 | 2005-08-31 | Synovo Gmbh | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| CN114007625A (zh) * | 2019-04-18 | 2022-02-01 | 阿祖拉眼科有限公司 | 用于治疗眼病的化合物和方法 |
-
2021
- 2021-10-20 JP JP2023524276A patent/JP2023546453A/ja active Pending
- 2021-10-20 WO PCT/IB2021/000707 patent/WO2022084738A2/fr not_active Ceased
- 2021-10-20 CA CA3196145A patent/CA3196145A1/fr active Pending
- 2021-10-20 MX MX2023004537A patent/MX2023004537A/es unknown
- 2021-10-20 KR KR1020237016470A patent/KR20230110515A/ko active Pending
- 2021-10-20 AU AU2021363702A patent/AU2021363702A1/en not_active Abandoned
- 2021-10-20 IL IL302173A patent/IL302173A/en unknown
- 2021-10-20 EP EP21882226.0A patent/EP4232149A4/fr active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013003731A2 (fr) * | 2011-06-29 | 2013-01-03 | Insite Vision Incorporated | Méthodes permettant de traiter un dysfonctionnement récurrent des glandes de meibomius et de réduire la fréquence de récurrence |
| WO2018215638A1 (fr) * | 2017-05-26 | 2018-11-29 | Novaliq Gmbh | Compositions pharmaceutiques contenant de l'azithromycine |
Non-Patent Citations (1)
| Title |
|---|
| XIAO-MING YAN ET AL: "Emerging treatment options for meibomian gland dysfunction", CLINICAL OPHTHALMOLOGY, 1 September 2013 (2013-09-01), pages 1797, XP055294421, DOI: 10.2147/OPTH.S33182 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2023004537A (es) | 2023-06-15 |
| EP4232149A2 (fr) | 2023-08-30 |
| AU2021363702A9 (en) | 2024-02-08 |
| IL302173A (en) | 2023-06-01 |
| JP2023546453A (ja) | 2023-11-02 |
| WO2022084738A3 (fr) | 2022-06-30 |
| CA3196145A1 (fr) | 2022-04-28 |
| AU2021363702A1 (en) | 2023-06-15 |
| KR20230110515A (ko) | 2023-07-24 |
| WO2022084738A2 (fr) | 2022-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3826666A4 (fr) | Compositions et méthodes de traitement de maladies associées à la nrp2 | |
| EP3969597A4 (fr) | Compositions et procédés pour le traitement de maladies médiées par l'atpase | |
| EP3902525A4 (fr) | Compositions pharmaceutiques ophtalmiques et procédés de traitement d'une maladie de surface oculaire | |
| EP4415755A4 (fr) | Compositions ciblant ace2 et méthodes de traitement de la covid-19 | |
| EP3600286A4 (fr) | Composés et procédés pour le traitement de maladies parasitaires | |
| EP4165025A4 (fr) | Compositions et méthodes de traitement et de prévention de troubles neurologiques | |
| EP4359405A4 (fr) | Dérivés de bêta-lactame pour traiter des maladies | |
| EP3740592A4 (fr) | Méthodes et compositions pour le traitement d'une maladie vasculaire | |
| EP4213891A4 (fr) | Méthodes de traitement d'une maladie neurologique | |
| EP4232149A4 (fr) | Composés et procédés pour le traitement de troubles oculaires | |
| EP3990090A4 (fr) | Cathéter d'administration et méthode de traitement de maladie | |
| EP4323359A4 (fr) | Composés tétracycliques pour le traitement de troubles cérébraux | |
| EP3893721A4 (fr) | Méthode et dispositif de traitement d'un trouble oculaire | |
| EP4277988A4 (fr) | Compositions et méthodes de traitement de la maladie de fabry | |
| EP4392423A4 (fr) | Composés de quinazoline pour le traitement d'une maladie | |
| EP4346813A4 (fr) | Méthodes de traitement de vasculopathies rétiniennes | |
| EP4437108A4 (fr) | Compositions et méthodes pour le traitement de troubles neurodégénératifs | |
| EP4419101A4 (fr) | Méthodes de traitement de troubles du snc | |
| EP4370153A4 (fr) | Méthodes de traitement de maladies neurologiques | |
| EP4210755A4 (fr) | Compositions et méthodes de traitement de troubles neurologiques | |
| EP4188346A4 (fr) | Compositions de nobiletine et méthodes pour le traitement et la prévention de la covid-19 et de pathologies associées | |
| EP4398986A4 (fr) | Méthodes de traitement de maladies neurodégénératives | |
| EP4398987A4 (fr) | Méthodes de traitement de maladies neurodégénératives | |
| EP4398988A4 (fr) | Méthodes de traitement de maladies neurodégénératives | |
| EP4232034A4 (fr) | Composés et procédés pour le traitement de troubles oculaires |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20230424 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61P0017000000 Ipc: C07H0017000000 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20241111 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 27/02 20060101ALI20241105BHEP Ipc: A61P 17/00 20060101ALI20241105BHEP Ipc: C07H 17/00 20060101AFI20241105BHEP |